BioCatalystWatch
KYNBWorkspace / KYNB / OverviewCompany library
Price
Market cap
Next catalystPhase 3 initiation goal in Q1 2027, subject to a strategic partnership or external capital raiseroxadustat — planned pivotal Phase 3 LR-MDS trial · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

roxadustat

HIF prolyl hydroxylase

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

roxadustat

HIF prolyl hydroxylase

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

roxadustat

HIF prolyl hydroxylase

PreINDP1P2P3FilingApproved
FG-3175

CCR8

PreINDP1P2P3FilingApproved
HFB1011

CCR8

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

roxadustat

HIF prolyl hydroxylase

Approved

PreINDP1P2P3FilingApproved

History / paused

roxadustat

HIF prolyl hydroxylase

PreINDP1P2P3FilingApproved

CTGF

PreINDP1P2P3FilingApproved

CCR8

PreINDP1P2P3FilingApproved

Galectin-9

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

KYNB PR & News

PR & News

KYNB SEC archive